Half-Life.

The science of optimization.

Compound

Growth Hormone Secretagogues

GH-releasing peptides (ipamorelin, GHRP-2, CJC-1295)

Not FDA-approved (as supplements)WADA-prohibited (S2)Research use only

What it is

Growth hormone secretagogues are peptides that stimulate pituitary release of growth hormone via ghrelin-type or GHRH-type receptors.[1] The category includes ipamorelin, GHRP-2, and CJC-1295. Marketed for recovery, body-composition, and sleep purposes.

Regulatory status

Not FDA-approved as supplements or drugs at consumer scale. WADA prohibits the class under S2 (peptide hormones, growth factors, and related substances).[2] Sold in research channels with 'not for human consumption' labeling.

State of the evidence

Short-term pharmacodynamic studies confirm acute increases in GH and downstream IGF-1 markers.[1] Evidence for the marketed outcomes in healthy adults — sleep quality, recovery, body composition — is limited and not established at the standard required for clinical claims.

Sources

  1. [1]Drugs.com / WADA, 'S2: Peptide hormones, growth factors, and related substances.'
  2. [2]WADA, 'Prohibited List.'

Educational reference only. Not medical advice. No dosing or protocols are published here.

The Half-Life Brief

Research worth reading. No hype.

Get evidence-focused breakdowns of peptide research, metabolic health, longevity, performance and emerging science.

Research summaries, not medical advice. Unsubscribe anytime.